natgillin/translations-raw huggingface dataset:
The effect of breast-feeding your baby in the week after taking this medicine is not known.
Učinek dojenja v tednu po uporabi tega zdravila ni znan.
If you become pregnant despite taking ellaOne, you are encouraged to ask your doctor to register your pregnancy in an official registry.
Če zanosite kljub uporabi zdravila ellaOne, prosite zdravnika, naj zapiše vašo nosečnost v uradni register.
It has minimal affinity to the androgen receptor and no affinity for the human estrogen or mineralocorticoid receptors.
Ima minimalno afiniteto za androgenski receptor in nobene afinitete za estrogenske ali mineralokortikoidne receptorje pri človeku.
If you have taken emergency contraception and you do not use a regular contraceptive method (or do not have a contraceptive method that suits you), talk to your doctor or family planning clinic for advice.
Če ste vzeli nujno kontracepcijo in ne uporabljate redne kontracepcijske metode (ali nimate kontracepcijske metode, ki bi vam ustrezala), se posvetujte s svojim zdravnikom ali kliniko za načrtovanje družine.
It is important to know that the occurrence of uterine bleeding does not rule out ectopic pregnancy.
Pomembno je vedeti, da pojav krvavitve iz maternice ne izključuje zunajmaternične nosečnosti.
Information from reproductive toxicity studies is limited due to the absence of exposure measurement in these studies.
Podatki iz študij vpliva na sposobnost razmnoževanja so omejeni zaradi pomanjkanja meritev izpostavljenosti v teh študijah.
Nevertheless it is important that any pregnancy in a woman who has taken ellaOne be reported to www.hra-pregnancy-registry.com.
Kljub temu pa je pomembno poročati o vsaki nosečnosti pri ženski, ki je vzela zdravilo ellaOne, na spletnem mestu www.hra-pregnancyregistry.com.
BMI (kg/m2)
ITM (kg/m2)
Vaginal Ring
Vaginalni obroček
At doses which were low enough to maintain gestation in the animal species, no teratogenic effects were observed.
Pri odmerkih za živali, ki so bili dovolj majhni, da so dopuščali gestacijo, niso opazili teratogenih učinkov.
If you have used any of the medicines listed below during the last 4 weeks, ellaOne may be less suitable for you.
Če ste v zadnjih 4 tednih uporabili katero od spodaj naštetih zdravil, je zdravilo ellaOne morda manj primerno za vas.
Ulipristal acetate has an embryolethal effect in rats, rabbits (at repeated doses above 1 mg/kg) and in monkeys.
Ulipristalacetat ima letalni učinek na zarodek pri podganah, kuncih (pri ponavljajočih se odmerkih, ki presegajo 1 mg/kg) in opicah.
By taking them both together, you might make this medicine less effective.
Sočasna uporaba lahko povzroči, da bo to zdravilo manj učinkovito.
The purpose of this web-based registry is to collect safety information from women who have taken ellaOne during pregnancy or who become pregnant after ellaOne intake.
Namen tega spletnega registra je zbiranje podatkov o varnosti pri ženskah, ki so vzele zdravilo ellaOne med nosečnostjo ali ki zanosijo po zaužitju zdravila ellaOne.
This medicine is suitable for any woman of childbearing age, including adolescents.
To zdravilo je primerno za vse ženske v rodni dobi, vključno z mladostnicami.
Therefore, ellaOne is still recommended for all women regardless of their weight or BMI.
Zdravilo ellaOne se zato še vedno priporoča pri vseh ženskah, ne glede na telesno maso ali ITM.
Pregnancy rate 0.00% 1.23% 1.29% 2.57%
Delež nosečnosti 0,00 % 1,23 % 1,29 % 2,57 % Interval zaupanja 0,00-2,84
Odds ratio [95% CI] of pregnancy risk, ulipristal acetate vs levonorgestrel2
Kvocient tveganja [95% CI] za nosečnosti, ulipristalacetat versus levonorgestrel2
MORE ABOUT REGULAR CONTRACEPTION
VEČ O REDNI KONTRACEPCIJI
Use in women with severe asthma treated by oral glucocorticoid is not recommended.
Uporabe pri ženskah s hudo astmo, ki se zdravijo s peroralnimi glukokortikoidi, se ne priporoča.
In approximately 7% of the women, menstrual periods occurred more than 7 days earlier than expected.
Pri približno 7% žensk se je menstruacijski ciklus začel več kot 7 dni pred predvidenim datumom.
The timing of ovulation cannot be predicted and therefore the tablet should be taken as soon as possible after unprotected intercourse.
Časa ovulacije ni mogoče predvideti, zato je treba vzeti tableto čim prej po nezaščitenem spolnem odnosu.
Post-marketing experience: the adverse reactions spontaneously reported in post-marketing experience were similar in nature and frequency to the safety profile described during the phase III program.
Izkušnje v obdobju trženja: neželeni učinki, o katerih so ženske spontano poročale v obdobju trženja, so bili po naravi in pogostnosti podobni varnostnemu profilu, opisanemu med III. fazo programa.
If you do not have a regular method of contraception, talk to your doctor or healthcare professional to choose one that is suitable for you.
Če nimate redne kontracepcijske metode, se posvetujte s svojim zdravnikom ali drugim zdravstvenim delavcem in izberite eno, ki je primerna za vas.
Adolescents: the safety profile observed in women less than 18 years old in studies and post-marketing is similar to the safety profile in adults during the phase III program (see section 4.2).
Mladostnice: varnostni profil pri ženskah, starih manj kot 18 let, v študijah in v obdobju trženja, je podoben varnostnemu profilu pri odraslih v III. fazi programa (glejte poglavje 4.2).
Special populations Renal impairment
Posebne populacije Okvara ledvic
Such high doses were well-tolerated; however, these women had a shortened menstrual cycle (uterine bleeding occurring 2-3 days earlier than would be expected) and in some women, the duration of bleeding was prolonged, although not excessive in amount (spotting).
Tako visoke odmerke so dobro prenesle; vendar pa so poročale o skrajšanem menstruacijskem ciklusu (do menstrualne krvavitve je prišlo 2-3 dni bolj zgodaj kot je bilo pričakovano), pri nekaterih ženskah pa je bilo tudi trajanje krvavitve podaljšano, ni pa bila krvavitev bolj obilna (šibka krvavitev).
E-mail: info-ella@hra-pharma.com
E-pošta: info-ella@hra-pharma.com
In any case, women should be advised to adopt a regular method of contraception.
Ženskam je treba v vsakem primeru svetovati uporabo redne kontracepcije.
Your doctor may prescribe another type of (non-hormonal) emergency contraceptive, i.e. a Cu-IUD.
Vaš zdravnik vam lahko predpiše drugo vrsto (nehormonske) nujne kontracepcije, tj. Cu-IUD.
Most findings in general toxicity studies were related to its mechanism of action as a modulator of progesterone and glucocorticoid receptors, with antiprogesterone activity observed at exposures similar to therapeutic levels.
Večina ugotovitev iz splošnih študij toksičnosti se je nanašala na mehanizem delovanja kot modulator progesteronskih in glukokortikoidnih receptorjev, pri čemer je bilo antiprogesteronsko delovanje opaženo pri izpostavljenosti, podobni terapevtskim odmerkom.
Tell your pharmacist, doctor or other healthcare professional if you are taking or have recently taken any other medicines, including medicines obtained without a prescription or herbal medicines.
Obvestite farmacevta, zdravnika ali drugega zdravstvenega delavca, če jemljete ali ste pred kratkim jemali katero koli drugo zdravilo, vključno z zdravili, ki so na voljo brez recepta, ali zdravili rastlinskega izvora.
It should in no instance replace a regular contraceptive method.
V nobenem primeru ne sme nadomestiti redne kontracepcije.
Limited human data regarding pregnancy exposure to ellaOne do not suggest any safety concern.
Omejeni podatki, pridobljeni pri ljudeh glede izpostavljenosti zdravilu ellaOne med nosečnostjo, ne kažejo nobenih varnostnih zadržkov.
Emergency contraception will not affect your fertility.
Nujna kontracepcija ne bo vplivala na vašo plodnost.
The majority of women (74.6%) in the phase III studies had their next menstrual period at the expected time or within ± 7 days, while 6.8% experienced menses more than 7 days earlier than expected and 18.5% had a delay of more than 7 days beyond the anticipated onset of menses.
Večina žensk (74,6 %) je v študiji III. faze dobila naslednjo menstruacijo ob predvidenem času ali v obdobju ± 7 dni, 6,8 % žensk je dobilo menstruacijo več kot 7 dni pred predvidenim datumom, pri 18,5 % pa je menstruacija zamujala več kot 7 dni po predvidenem datumu.
Although no teratogenic potential has been observed, animal data are insufficient with regard to reproduction toxicity (see section 5.3).
Čeprav niso opazili nobenega teratogenega potenciala, študije na živalih niso zadostne za oceno vpliva na sposobnost razmnoževanja (glejte poglavje 5.3).
Emergency contraception does not protect against sexually transmitted infections
Nujna kontracepcija ne ščiti pred spolno prenosljivimi okužbami.
If you have used certain other medicines in the last 4 weeks, in particular for epilepsy, tuberculosis, HIV infection or herbal medicines containing St. John´s wort (see leaflet), ellaOne may work less effectively.
Če ste v zadnjih 4 tednih jemali določena druga zdravila, zlasti za zdravljenje epilepsije, tuberkuloze, za zdravljenje okužbe z virusom HIV ali zdravila rastlinskega izvora, ki vsebujejo šentjanževko (glejte navodilo), je lahko zdravilo ellaOne manj učinkovito.
If you become pregnant despite taking this medicine, there is no evidence that it will affect your pregnancy.
Če zanosite kljub uporabi tega zdravila, ni dokazov, da bo zdravilo vplivalo na nosečnost.
If vomiting occurs within 3 hours of the tablet intake, another tablet should be taken.
Če se v 3 urah po zaužitju tablete pojavi bruhanje, je treba vzeti še eno tableto.
After taking this medicine, some women experience dizziness, drowsiness, blurred vision and/or loss of concentration (see section 4).
Po uporabi tega zdravila se pri nekaterih ženskah pojavijo omotica, zaspanost, zamegljen vid in/ali poslabšanje koncentracije (glejte poglavje 4).
ellaOne does not work if you are already pregnant.
Zdravilo ellaOne ne deluje, če ste že noseči.
Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicinal product.
Ženske z redko dedno intoleranco za galaktozo, laponsko obliko zmanjšane aktivnosti laktaze ali malabsorpcijo glukoze/galaktoze ne smejo jemati tega zdravila.
Influenza
- gripa
USEFUL INFORMATION ABOUT CONTRACEPTION MORE ABOUT EMERGENCY CONTRACEPTION
UPORABNE INFORMACIJE O KONTRACEPCIJI VEČ O NUJNI KONTRACEPCIJI
This is especially important if you have severe abdominal (stomach) pain or bleeding or if you have previously had a pregnancy outside the womb, tubal surgery or long term (chronic) genital infection.
To je še posebej pomembno, če imate hude bolečine v trebuhu ali krvavitev ali če ste v preteklosti že imeli zunajmaternično nosečnost, operacijo jajcevodov ali dolgotrajno (kronično) okužbo spolovil.
Some symptoms such as breast tenderness and abdominal (stomach) pain, throwing up (vomiting), feeling sick (nausea) are also possible signs of pregnancy.
Nekateri simptomi, kot so občutljive dojke in bolečine v trebuhu, bruhanje, slabost s siljenjem na bruhanje (navzea), so tudi možni znaki nosečnosti.
After taking the tablet, it is normal for your next period to be a few days late.
Po jemanju tablete je normalno, če naslednja menstruacija nastopi nekaj dni prepozno.
In the absence of specific studies, ulipristal acetate is not recommended.
Zaradi pomanjkanja specifičnih študij se uporaba ulipristalacetata ne priporoča.
When used for emergency contraception the mechanism of action is inhibition or delay of ovulation via suppression of the luteinising hormone (LH) surge.
Kadar se uporablja za nujno kontracepcijo, je mehanizem delovanja zaviranje ali odlaganje ovulacije, ki poteka prek zaviranja zvišanja ravni luteinizirajočega hormona (LH).
Emergency contraception can delay ovulation within a given menstrual cycle, but it will not stop you from becoming pregnant if you have unprotected sex again.
Nujna kontracepcija lahko odloži ovulacijo v danem menstrualnem ciklusu, vendar ne bo preprečila zanositve, če boste ponovno imeli nezaščiten spolni odnos.
During this time it is recommended to express and discard the breast milk in order to stimulate lactation.
V tem času je priporočljivo materino mleko iztisniti in zavreči, da se tako stimulira laktacija.
If you are already pregnant it will not interrupt an existing pregnancy.
Če ste že noseči, ne bo prekinilo obstoječe nosečnosti.
Speak to your doctor or pharmacist before using ellaOne when you use (or have recently used) any of the medicines stated above.
Pogovorite se s svojim zdravnikom ali farmacevtom preden uporabite zdravilo ellaOne, če uporabljate (ali ste pred kratkim uporabljali) katero izmed zgoraj naštetih zdravil.
P-glycoprotein (P-gp) substrates
Substrati P-glikoproteina (P-gp)
Similar results were obtained for the active mono-demethylated metabolite.
Podobni rezultati so bili pridobljeni tudi za aktivni monodemetilirani presnovek.
Adverse reactions listed below are classified according to frequency and system organ class using the following convention: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000), very rare (<1/10,000) and not known (cannot be estimated from the available data).
Spodaj našteti neželeni učinki so razvrščeni glede na pogostnost in organske sisteme v naslednji obliki: zelo pogosti (≥ 1/10), pogosti (od ≥ 1/100 do < 1/10), občasni (od ≥ 1/1.000 do < 1/100), redki (od ≥ 1/10.000 do < 1/1.000) in neznana (ni mogoče oceniti iz razpoložljivih podatkov).
Potential for ulipristal acetate to affect other medicinal products
Možnost vpliva ulipristalacetata na druga zdravila
For the full list of excipients, see section 6.1
Za celoten seznam pomožnih snovi glejte poglavje 6.1.
Excipients with known effect Each tablet contains 237 mg of lactose (as monohydrate).
Pomožne snovi z znanim učinkom Ena tableta vsebuje 237 mg laktoze (monohidrat).
As for any pregnancy, your doctor may want to check that the pregnancy is not outside the womb.
Kot pri vsaki nosečnosti bo zdravnik morda želel preveriti, ali je nosečnost zunajmaternična.
In case the next menstrual period is more than 7 days late, if the menstrual period is abnormal in character or if there are symptoms suggestive of pregnancy or in case of doubt, a pregnancy test should be performed.
Če naslednja menstruacija zamuja več kot 7 dni, če je menstruacija nenormalnega značaja, če se pojavijo simptomi, ki kažejo na nosečnost, ali v primeru dvoma je treba opraviti test nosečnosti.
Although the use of ulipristal acetate for emergency contraception does not contraindicate the continued use of regular hormonal contraception, ellaOne may reduce its contraceptive action (see section 4.5).
Čeprav uporaba ulipristalacetata za nujno kontracepcijo ne kontraindicira nadaljnje uporabe redne hormonske kontracepcije, lahko zdravilo ellaOne zmanjša njeno kontracepcijsko delovanje (glejte poglavje 4.5).
A minority (8.7%) of women reported intermenstrual bleeding lasting an average of 2.4 days.
Pri manjšemu deležu žensk (8,7 %) se je v času med dvema menstruacijama pojavila krvavitev, ki je trajala povprečno 2,4 dneva.
In vitro data indicate that ulipristal acetate and its active metabolite do not significantly inhibit CYP1A2, 2A6, 2C9, 2C19, 2D6, 2E1, and 3A4, at clinically relevant concentrations.
Podatki in vitro kažejo, da ulipristalacetat in njegov aktivni presnovek v klinično pomembnih koncentracijah nista pomembna zaviralca encimov CYP1A2, 2A6, 2C9, 2C19, 2D6, 2E1 in 3A4.
The mono-demethylated metabolite is pharmacologically active.
Monodemetiliran presnovek je farmakološko aktiven.
If you take more ellaOne than you should
Če ste vzeli večji odmerek zdravila ellaOne, kot bi smeli
Hypersensitivity to the active substance or to any of the excipients listed in section 6.1
Preobčutljivost na učinkovino ali katero koli pomožno snov, navedeno v poglavju 6.1.
Normal
Normalen
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder
Za vse morebitne nadaljnje informacije o tem zdravilu se lahko obrnete na predstavništvo imetnika dovoljenja za promet z zdravilom:
The clinical relevance of this interaction for single dose administration of ulipristal acetate as emergency contraception is not known.
Klinični pomen tega medsebojnega delovanja pri uporabi enega odmerka ulipristalacetata kot nujne kontracepcije ni znan.
This medicine is a contraceptive used to prevent a pregnancy from starting.
To zdravilo je kontracepcijsko sredstvo, ki se uporablja za preprečitev nastopa nosečnosti.
For women who have used enzyme-inducing drugs in the past 4 weeks, ellaOne is not recommended (see section 4.4) and non-hormonal emergency contraception (i.e. a copper intrauterine device (Cu-IUD)) should be considered.
Pri ženskah, ki so v zadnjih 4 tednih uporabljale zdravila, ki inducirajo encime, uporaba zdravila ellaOne ni priporočljiva (glejte poglavje 4.4), hkrati pa je treba razmisliti o nehormonski nujni kontracepciji (tj. bakrenem materničnem vložku (Cu-IUD)).
This medicine does not require any special storage conditions.
Za to zdravilo ne veljajo posebni pogoji shranjevanja.
If you have been told by your doctor or other healthcare professional that you have an intolerance to some sugars, tell your pharmacist before taking this medicine.
Če vam je zdravnik ali drug zdravstveni delavec povedal, da ne prenašate nekaterih sladkorjev, se pred uporabo tega zdravila posvetujte s farmacevtom.
This medicine will not protect you against HIV infection or any other sexually transmitted diseases (e.g. chlamydia, genital herpes, genital warts, gonorrhoea, hepatitis B and syphilis).
To zdravilo vas ne bo zaščitilo pred okužbo z virusom HIV ali drugimi spolno prenosljivimi boleznimi (kot so klamidija, genitalni herpes, genitalne bradavice, gonoreja, hepatitis B in sifilis).
Therefore, if a woman wishes to start or continue using hormonal contraception, she can do so after using ellaOne, however, she should be advised to use a reliable barrier method until the next menstrual period.
Torej, če želi ženska začeti ali nadaljevati uporabo hormonske kontracepcije, to lahko stori po uporabi zdravila ellaOne, vendar ji je treba svetovati, naj do naslednje menstruacije uporablja zanesljivo pregradno metodo.
Contents of the pack and other information What ellaOne contains
Vsebina pakiranja in dodatne informacije Kaj vsebuje zdravilo ellaOne
Take the tablet without delay.
Ne odlašajte z zaužitjem tablete.
In an open-label clinical trial, which enrolled women who presented for emergency contraception and were treated with ulipristal acetate between 48 and 120 hours after unprotected intercourse, a pregnancy rate of 2.1% (26/1241) was observed.
V odprtem kliničnem preskušanju, v katerem so sodelovale ženske, ki so potrebovale nujno kontracepcijo ter so prejele ulipristalacetat v času od 48 do 120 ur po nezaščitenem spolnem odnosu ali neučinkoviti kontracepciji, je bil odstotek nosečnosti 2,1 % (26/1241).
Pregnancy ellaOne is not intended for use during pregnancy and should not be taken by any woman suspected or known to be pregnant (see section 4.2).
Zdravilo ellaOne ni namenjeno uporabi med nosečnostjo in ga ne sme vzeti nobena ženska, ki sumi ali ve, da je noseča (glejte poglavje 4.3).
You should take the tablet as soon as possible after sex, and within a maximum of 5 days (120 hours).
Tableto morate vzeti čim prej po spolnem odnosu in najpozneje po 5 dneh (120 urah).
Unprotected sex at any time during your cycle can lead to pregnancy.
Nezaščiten spolni odnos kadar koli med menstrualnim ciklusom lahko privede do nosečnosti.
Ulipristal acetate is an emergency contraceptive that decreases pregnancy risk after unprotected intercourse but does not confer contraceptive protection for subsequent acts of intercourse.
Ulipristalacetat je nujno kontracepcijsko sredstvo, ki zmanjšuje tveganje za nosečnost po nezaščitenem spolnem odnosu, vendar ne zagotavlja kontracepcijske zaščite za nadaljnje spolne odnose.
No pharmacokinetic studies with ulipristal acetate have been performed in females with impaired renal or hepatic function.
Farmakokinetičnih študij z ulipristalacetatom pri ženskah z oslabljeno ledvično ali jetrno funkcijo niso izvedli.
ellaOne is not to be used for regular contraception
Zdravilo ellaOne se ne sme uporabljati kot redna kontracepcijska metoda.
Ulipristal acetate is highly bound (>98%) to plasma proteins, including albumin, alpha-l-acid glycoprotein, and high density lipoprotein.
Ulipristalacetat se močno veže (> 98 %) na plazemske beljakovine, vključno z albumini, alfa-1glikoproteini in lipoproteini visoke gostote.
Limited and inconclusive data suggest that there may be reduced efficacy of ellaOne with increasing body weight or body mass index (BMI) (see section 5.1).
Omejeni in nedokončni podatki kažejo, da se lahko učinkovitost zdravila ellaOne manjša z večanjem telesne mase ali indeksa telesne mase (ITM) (glejte poglavje 5.1).
Ulipristal acetate is not intended for use during pregnancy and should not be taken by any woman suspected or known to be pregnant.
Ulipristalacetat ni namenjen za uporabo med nosečnostjo in ga ne sme vzeti nobena ženska, ki sumi ali ve, da je noseča.
In all women, emergency contraception should be taken as soon as possible after unprotected intercourse, regardless of the woman's body weight or BMI.
Pri vseh ženskah je treba nujno kontracepcijo vzeti čim prej po nezaščitenem spolnem odnosu, ne glede na telesno maso ali ITM ženske.
Limited and inconclusive data from clinical trials suggest a possible trend for a reduced contraceptive efficacy of ulipristal acetate with high body weight or BMI (see section 4.4).
Omejeni in nedokončni podatki iz kliničnih preskušanj kažejo morebiten trend za zmanjšano učinkovitost kontracepcije ulipristalacetata pri veliki telesni masi ali ITM (glejte poglavje 4.4).
There were no safety differences in these subjects in terms of incidence and severity of adverse reactions, change in duration or volume of menses or incidence of intermenstrual bleeding.
Med temi ženskami niso bile opažene razlike v varnosti zdravila glede incidence in resnosti neželenih reakcij, sprememb v trajanju menstruacije ali količini menstrualne krvi ali glede incidence krvavitev v času med dvema menstruacijama.
The CYP3A4 inhibitor ritonavir can also have an inducing effect on CYP3A4 when ritonavir is used for a longer period.
Zaviralec CYP3A4, ritonavir, ima lahko prav tako inducirajoče učinke na CYP3A4, če je njegova uporaba dolgotrajna.
Laboratorios León Farma S.A. C/ La Vallina, s/n Pol. Ind. Navatejera 24008 Navatejera, León Spain
C/ La Vallina, s/n Pol. Ind. Navatejera 24008 Navatejera, León
In all women, emergency contraception should be taken as soon as possible after unprotected intercourse.
Pri vseh ženskah je treba nujno kontracepcijo uporabiti čim prej po nezaščitenem spolnem odnosu.
Take one tablet as soon as possible after unprotected sex or contraceptive failure.
Vzemite eno tableto čim prej po nezaščitenem spolnem odnosu ali neučinkoviti kontracepciji.
Emergency contraception
Nujna kontracepcija
In 18.5% of the women a delay of more than 7 days occurred, and in 4% the delay was greater than 20 days.
Pri približno 18,5% žensk je menstruacijski ciklus zamujal več kot 7 dni, pri 4 % žensk pa je bila zamuda daljša od 20 dni.
Women should be advised to use a reliable barrier method for all subsequent acts of intercourse until the next menstrual period.
Ženskam je treba svetovati, naj do naslednje menstruacije uporabljajo zanesljivo pregradno metodo za vse nadaljnje spolne odnose.
This medicine may make regular hormonal contraceptives, like pills and patches, temporarily less effective.
Druga kontracepcijska sredstva in zdravilo ellaOne Zaradi tega zdravila je lahko redna hormonska kontracepcija, kot so tablete in obliži, začasno manj učinkovita.
Women who become pregnant after taking ulipristal acetate should contact their doctor (see section 4.6).
Ženske, ki zanosijo po jemanju ulipristalacetata, se morajo posvetovati z zdravnikom (glejte poglavje 4.6).